Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 20:16:883-893.
doi: 10.2147/PGPM.S407179. eCollection 2023.

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies

Affiliations

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies

Deepa Selvi Rani et al. Pharmgenomics Pers Med. .

Abstract

Background: Mutations in Myosin Binding Protein C (MYBPC3) are one of the most frequent causes of cardiomyopathies in the world, but not much data are available in India.

Methods: We carried out targeted direct sequencing of MYBPC3 in 115 hypertrophic (HCM) and 127 dilated (DCM) cardiomyopathies against 197 ethnically matched healthy controls from India.

Results: We detected 34 single nucleotide variations in MYBPC3, of which 19 were novel. We found a splice site mutation [(IVS6+2T) T>G] and 16 missense mutations in Indian cardiomyopathies [5 in HCM; E258K, T262S, H287L, R408M, V483A: 4 in DCM; T146N, V321L, A392T, E393K and 7 in both HCM and DCM; L104M, V158M, S236G, R272C, T290A, G522E, A626V], but those were absent in 197 normal healthy controls. Interestingly, we found 7 out of 16 missense mutations (V158M, E258K, R272C, A392T, V483A, G522E, and A626V) in MYBPC3 were altering the evolutionarily conserved native amino acids, accounted for 8.7% and 6.3% in HCM and DCM, respectively. The bioinformatic tools predicted that those 7 missense mutations were pathogenic. Moreover, the co-segregation of those 7 mutations in families further confirmed their pathogenicity. Remarkably, we also identified compound mutations within the MYBPC3 gene of 6 cardiomyopathy patients (5%) with more severe disease phenotype; of which, 3 were HCM (2.6%) [(1. K244K + E258K + (IVS6+2T) T>G); (2. L104M + G522E + A626V); (3. P186P + G522E + A626V]; and 3 were DCM (2.4%) [(1. 5'UTR + A392T; 2. V158M+G522E; and 3.V158M + T262T + A626V].

Conclusion: The present comprehensive study on MYBPC3 has revealed both single and compound mutations in MYBPC3 and their association with disease in Indian Population with Cardiomyopathies. Our findings may perhaps help in initiating diagnostic strategies and eventually recognizing the targets for therapeutic interventions.

Keywords: DCM; HCM; MYBPC3; cardiomyopathy; sarcomere genes.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
(A) Schematic representation of the MYBPC3 structure. (B) Highlighted are the observed exonic, and splice sites variations. (The 10 amino acid substitutions, and 1 splice-site mutation were indicated in red color). (C) Electropherograms (arrows) showing 10 missense mutations [V158M, E258K, R272C, H287L, V321L, E392T, R408M, V483A, and a G522E, A626V), and a splice-donor mutation (T>G[IVS6+2T]) in the MYBPC3 gene. (D) Multiple alignments of amino acid sequences in the MYBPC3gene of several species, showing that those were highly conserved across many species.

References

    1. Previs MJ, Beck Previs S, Gulick J, Robbins J, Warshaw DM. Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science. 2012;337(6099):1215–1218. doi: 10.1126/science.1223602 - DOI - PMC - PubMed
    1. Daehmlow S, Erdmann J, Knueppel T, et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun. 2002;298(1):116–120. doi: 10.1016/s0006-291x(02)02374-4 - DOI - PubMed
    1. Lee KH, Sulbaran G, Yang S, et al. Interacting-heads motif has been conserved as a mechanism of myosin II inhibition since before the origin of animals. Proc Natl Acad Sci USA. 2018;115(9):E1991–E2000. doi: 10.1073/pnas.1715247115 - DOI - PMC - PubMed
    1. Pfuhl M, Gautel M. Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom? J Muscle Res Cell Motil. 2012;33(1):83–94. doi: 10.1007/s10974-012-9291-z - DOI - PubMed
    1. Barefield D, Sadayappan S. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol. 2010;48(5):866–875. doi: 10.1016/j.yjmcc.2009.11.014 - DOI - PMC - PubMed